Medical Net Stock

Medical Net EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Medical Net (3645.T) as of Aug 8, 2026 is 26.68. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 8.84 — a change of 201.96% (higher).

EV/EBIT

26.68

YoY

201.96%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Medical Net is 2026 26.68 . EV/EBIT (Enterprise Value to EBIT) of Medical Net was 2025 8.84 . It decreases by 201.96% higher compared to the previous year.

The Medical Net EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
16.68 base
Jan 1, 2019
15.60 base
Jan 1, 2020
41.87 base
Jan 1, 2021
11.70 base
Jan 1, 2022
8.02 base
Jan 1, 2023
8.85 base
Jan 1, 2024
9.61 base
Jan 1, 2025
26.92 base
YEARPRICE-TO-EBIT
2025 26.92
2024 9.61
2023 8.85
2022 8.02
2021 11.70
2020 41.87
2019 15.60
2018 16.68
2017 26.51
2016 15.39
Access this data via the Eulerpool API

Medical Net Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Medical Net's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Medical Net's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Medical Net's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Medical Net grows earnings faster than its peers.

Medical Net Stock analysis

What does Medical Net do? Medical Net is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medical Net stock

EV/EBIT (Enterprise Value to EBIT) of Medical Net is 26.68 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Medical Net changed from 8.84 to 26.68, representing a 201.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Medical Net since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Medical Net with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Medical Net

All Key Metrics — Medical Net